Get the Stockscreener App
0.00
100.00%
-0.6063
23 Andme Holding Co stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.6063
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$82.91M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
0.00
EPS:
-1.11
Net Cash Flow:
$-194.28M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$7.88
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
223 N. MATHILDA AVE., SUNNYVALE
Compare ME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
463.84 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
196.75 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
674.94 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.33 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.02 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
Judge OKs sale of 23andMe in bankruptcy case - MSN
WilmerHale Can Advise 23andMe Ch. 11 Data Ombudsman - Law360
23andMe Ombudsman Beats DOJ Pushback in Bid to Hire WilmerHale - Bloomberg Law News
House Bill Would Close Privacy Loophole Exposed by 23andMe Bankruptcy (Jul 18, 2025) - VitalLaw.com
23andMe Bankruptcy Update: How the Proceedings Highlight Best Practices for Handling and Transferring Genetic Data and Personal Information - Foley Hoag
23andMe data breach class action settlement - Class Action Lawsuits
Lam Research Corporation shares rise 1.72% premarket after TTAM Research Institute completed acquisition of 23andMe Holding Co. - AInvest
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid - MSN
23andMe Holding says debtors repay all outstanding indebtedness, terminate loan agreement - MarketScreener
23andMe Completes Asset Sale Amid Bankruptcy - TipRanks
Press Release: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - 富途牛牛
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - The Manila Times
23andMe Founder Saves DNA Testing Service: Nonprofit TTAM Takes Over Customer Data and Research - Stock Titan
23andMe sale approved by judge in bankruptcy case - MSN
23andMe Sale to Proceed as California Continues Appeal (Correct) - Bloomberg Law News
WilmerHale, US Trustee Spar Over Work In 23andMe Ch. 11 - Law360
US judge won't block 23andMe bankruptcy sale to co-founder - Reuters
Judge briefly pauses 23andMe bankruptcy sale amid California's appeal - Reuters
23andMe Privacy Reviewer Defends WilmerHale as Choice of Counsel - Bloomberg Law News
Calif. Fails To Pause 23andMe's Sale During Appeal - Law360
California fails to stop 23andMe founder from re-acquiring company - Reuters
Court quashes appeal relating to 23andMe’s insolvency after global data breach - Law360 Canada
California Appeals 23andMe Genetic Data Sale in Bankruptcy Case - Bloomberg Law News
The Former CEO of 23andMe Bought the Company Back, and I'm Tentatively Optimistic - Lifehacker
Judge approves 23andMe sale - The San Joaquin Valley Sun
Judge approves sale of genetics company 23andMe to founder’s nonprofit group - Washington Times
Judge OKs 23AndMe's $305M Genetic Data Asset Sale - Law360
23andMe wins court OK for $305M asset sale; equity risk flagged | ME SEC FilingForm 8-K - Stock Titan
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation - GlobeNewswire
23andMe's Massive $305M Transformation: Founder Returns to Lead New Nonprofit Future - Stock Titan
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):